IRIS
PRIORI, SILVIA GIULIANA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 16.183
AS - Asia 12.916
EU - Europa 10.780
SA - Sud America 1.671
AF - Africa 244
OC - Oceania 44
Continente sconosciuto - Info sul continente non disponibili 21
Totale 41.859
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 15.924
CN - Cina 7.468
SG - Singapore 2.727
IE - Irlanda 2.601
UA - Ucraina 1.688
HK - Hong Kong 1.566
BR - Brasile 1.383
DE - Germania 1.186
RU - Federazione Russa 1.184
IT - Italia 1.143
FI - Finlandia 917
SE - Svezia 779
GB - Regno Unito 596
VN - Vietnam 378
FR - Francia 270
CA - Canada 163
IN - India 133
AR - Argentina 107
JP - Giappone 102
AT - Austria 88
ZA - Sudafrica 76
BD - Bangladesh 74
MX - Messico 69
NL - Olanda 69
PL - Polonia 58
IQ - Iraq 57
ID - Indonesia 54
PK - Pakistan 50
TR - Turchia 49
ES - Italia 46
EC - Ecuador 43
MU - Mauritius 40
UZ - Uzbekistan 31
AU - Australia 30
CO - Colombia 28
IR - Iran 28
PY - Paraguay 27
MA - Marocco 26
VE - Venezuela 26
BE - Belgio 23
EG - Egitto 20
IL - Israele 19
NP - Nepal 18
JO - Giordania 17
LT - Lituania 16
PH - Filippine 16
PT - Portogallo 16
UY - Uruguay 16
CL - Cile 15
PE - Perù 15
AE - Emirati Arabi Uniti 14
DZ - Algeria 14
SA - Arabia Saudita 14
CH - Svizzera 13
EU - Europa 13
KR - Corea 13
AZ - Azerbaigian 12
KE - Kenya 12
TN - Tunisia 12
CZ - Repubblica Ceca 11
SK - Slovacchia (Repubblica Slovacca) 11
BO - Bolivia 9
KZ - Kazakistan 9
NZ - Nuova Zelanda 9
SN - Senegal 9
LV - Lettonia 8
MY - Malesia 8
GR - Grecia 7
AL - Albania 6
BW - Botswana 6
TW - Taiwan 6
XK - ???statistics.table.value.countryCode.XK??? 6
AM - Armenia 5
BG - Bulgaria 5
BY - Bielorussia 5
DK - Danimarca 5
GE - Georgia 5
JM - Giamaica 5
KG - Kirghizistan 5
TH - Thailandia 5
BB - Barbados 4
BH - Bahrain 4
CG - Congo 4
LB - Libano 4
PA - Panama 4
QA - Qatar 4
BA - Bosnia-Erzegovina 3
BN - Brunei Darussalam 3
ET - Etiopia 3
GT - Guatemala 3
HR - Croazia 3
KH - Cambogia 3
KW - Kuwait 3
LU - Lussemburgo 3
MT - Malta 3
NG - Nigeria 3
NO - Norvegia 3
OM - Oman 3
SI - Slovenia 3
TT - Trinidad e Tobago 3
Totale 41.803
Salva come PNG Salva come JPEG
Città #
Dublin 2.596
Chandler 2.494
Jacksonville 2.152
Nanjing 1.747
Hong Kong 1.551
Dallas 1.321
Ashburn 1.182
Singapore 1.110
Beijing 957
Boardman 953
Nanchang 742
Princeton 651
Lawrence 586
Wilmington 540
Hebei 530
Changsha 499
Shenyang 462
Jiaxing 376
Medford 375
Los Angeles 369
Tianjin 316
Helsinki 305
San Genesio Ed Uniti 257
Buffalo 246
Hangzhou 243
Moscow 235
Milan 203
Shanghai 197
Woodbridge 197
Redondo Beach 188
New York 176
Ho Chi Minh City 138
Ann Arbor 125
São Paulo 121
Verona 112
Norwalk 107
Falls Church 94
The Dalles 90
Nuremberg 87
Falkenstein 84
Tokyo 84
Hanoi 82
Seattle 81
Munich 75
Guangzhou 64
Houston 61
Chicago 60
Toronto 60
Brooklyn 56
Des Moines 55
Kunming 53
Zhengzhou 50
Fairfield 49
Johannesburg 49
Rio de Janeiro 49
London 48
San Francisco 45
Warsaw 42
Jinan 41
Montreal 41
Rome 41
Washington 40
Columbus 39
Santa Clara 38
Stockholm 38
Vienna 37
Belo Horizonte 33
Ningbo 30
Council Bluffs 29
Tappahannock 29
Turku 29
Dearborn 28
Boston 27
Mexico City 27
Pavia 27
Brasília 25
Phoenix 24
Atlanta 23
Denver 23
Taizhou 23
Tashkent 23
Changchun 22
Chennai 21
Curitiba 20
Orem 20
Porto Alegre 20
Salvador 20
Brussels 18
Dhaka 18
Haiphong 18
Baghdad 17
Guayaquil 17
Lanzhou 17
Pune 17
Amman 16
Naples 16
Secaucus 16
Shijiazhuang 16
Ankara 15
Buenos Aires 15
Totale 26.831
Salva come PNG Salva come JPEG
Nome #
Task Force on the Management of Stable Angina Pectoris of the European Society of Cardiology; ESC Committee for Practice Guidelines (CPG). Guidelines on the management of stable angina pectoris: executive summary: the Task Force on the Management of Stable Angina Pectoris of the European Society of Cardiology 251
Calcio antagonisti e aritmie da riperfusione miocardica 194
From decision to shared-decision: Introducing patients' preferences into clinical decision analysis. 166
Tachicardia Ventricolare Polimorfa Catecolaminergica 150
Arrhythmogenic mechanisms in a mouse model of Catecholaminergic Polymorphic Ventricular Tachycardia. 146
A method of gene transfer for the treatment of recessive CPVT 143
American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents; European Society of Cardiology Committee for Practice Guidelines. American college of cardiology/european society of cardiology clinical expert consensus documen on hypertrophic cardiomyopathy. A report of the american college of cardiology foundation task force on clinical expert consensus documents and the european society of cardiology committee for practice guidelines 139
Effects of Anacetrapib in Patients with Atherosclerotic Vascular Disease 130
2011 ACCF/AHA/HRS focused updates incorporated into the ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: a report of the American College of Cardiology Foundation/ American Heart Association Task Force on practice guidelines. American College of Cardiology Foundation/American Heart Association Task Force. 129
A cardiac arrhythmia syndrome caused by loss of ankyrin-B function 129
2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC 127
Cardiovascular pre-participation screening of young competitive athletes for prevention of sudden death: proposal for a common European protocol: Consensus Statement of the Study Group of Sport Cardiology of the Working Group of Cardiac Rehabilitation and Exercise Physiology and the Working Group of Myocardial and Pericardial Diseases of the European Society of Cardiology 123
Genetic testing in the long QT syndrome: development and validation of an efficient approach to genotyping in clinical practice 119
La Sindrome di Brugada: aspetti clinici, criteri diagnostici, stratificazione prognostica. 117
[Electrophysiologic features of the modulation of ATP-dependent potassium channels]. 117
Task Force on Syncope, European Society of Cardiology.Guidelines on management (diagnosis and treatment) of syncope-update 2004. Executive Summary. 115
Aspetti elettrofisiologici della modulazione dei canali del potassio ATP-dipendenti 115
[Idiopathic ventricular fibrillation: from a collection of clinical cases to a prospective evaluation. The U-CARE Steering Committee. Unexplained Cardiac Arrest Registry of Europe]. 115
La Sindrome di Brugada 114
A newly charactarized SCN5A mutation underlying Brugada Syndrome unmasked by Hyperthermia 112
[2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac Death. The Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of the European Society of Cardiology] 111
2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC)Developed with the special contribution of the Heart Failure Association (HFA) of the ESC 110
2010 focused update of ESC Guidelines on device therapy in heart failure: an update of the 2008 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure and the 2007 ESC Guidelines for cardiac and resynchronization therapy. Developed with the special contribution of the Heart Failure Association and the European Heart Rhythm Association 110
Abnormal Calcium Signalling and Sudden Cardiac Death Associated With Mutation of Calsequestrin. 109
European Society of Cardiology. Expert consensus document on the use of antiplatelet agents. The task force on the use of antiplatelet agents in patients with atherosclerotic cardiovascular disease of the European society of cardiology. 107
Gene-specific therapy for inherited arrhythmogenic diseases 107
Images in cardiovascular medicine. Endocardial implantation of a cardioverter-defibrillator in a 13-month-old child affected by long-QT syndrome and syndactyly. 106
Arrhythmogenic Right Ventricular Cardiomyopathy: Clinical Course and Predictors of Arrhythmic Risk 106
Task Force. Guidelines on diagnosis and treatment of pulmonary arterial hypertension. The Task Force on Diagnosis and Treatment of Pulmonary Arterial Hypertension of the European Society of Cardiology. 104
Abnormal Interactions of Calsequestrin With the Ryanodine Receptor Calcium Release Channel Complex Linked to Exercise-Induced Sudden Cardiac Death 104
Interplay Between Genetic Substrate, QTc Duration, and Arrhythmia Risk in Patients With Long QT Syndrome 104
Evolving determinants of carotid atherosclerosis vulnerability in asymptomatic patients from the MAGNETIC observational study 104
Computer simulation of wild-type and mutant human cardiac Na+ current 103
Allele-Specific Silencing of Mutant mRNA Rescues Ultrastructural and Arrhythmic Phenotype in Mice Carriers of the R4496C Mutation in the Ryanodine Receptor Gene (RYR2). 103
Genetic causes of sudden cardiac death in the young. 103
Catecholaminergic Polymorphic Ventricular Tachycardia. 102
2019 HRS expert consensus statement on evaluation, risk stratification, and management of arrhythmogenic cardiomyopathy: Executive summary 102
Linee Guida. Task Force sulla Morte Cardiaca Improvvisa, Società Europea di Cardiologia. Riassunto delle raccomandazioni 101
Beyond Cohort Selection: An Analytics-Enabled i2b2 101
Clinical and Molecular Characterization of Patients with Catecholominergic Polymorphic Ventricular Tachycardia. 100
Risk stratification in the Long-QT Syndrome 100
Molecular strategies for the electrophysiologist 100
2010 Focused Update of ESC guidelines on device therapy in heart failure: An update of the 2008 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure and the 2007 ESC guidelines for cardiac and resynchronization therapy Developed with the special contribution of the Heart Failure Association and the European Heart Rhythm Association 100
Hydroquinidine Prevents Life-Threatening Arrhythmic Events in Patients With Short QT Syndrome 100
A Molecular Link between the Sudden Infant Death Syndrome and the Long-QT Syndrome. 100
2010 Focused Update of ESC Guidelines on device therapy in heart failure: an update of the 2008 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure and the 2007 ESC Guidelines for cardiac and resynchronization therapy. Developed with the special contribution of the Heart Failure Association and the European Heart Rhythm Association 99
FKBP12.6 deficiency and defective calcium release channel (ryanodine receptor) function linked to exercise-induced sudden cardiac death. 99
[2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death] 99
Natural History and Risk Stratification in Andersen-Tawil Syndrome Type 1 99
Spotlight on sudden cardiac death 98
2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy: The Task Force for the Diagnosis and Management of Hypertrophic Cardiomyopathy of the European Society of Cardiology (ESC). 98
Information extraction from Italian medical reports: An ontology-driven approach 98
2019 HRS expert consensus statement on evaluation, risk stratification, and management of arrhythmogenic cardiomyopathy 98
Long QT syndrome and catecholaminergic VT 97
Big Data as a Driver for Clinical Decision Support Systems: A Learning Health Systems Perspective 96
Task Force on Clinical Expert Consensus Documents. American College of Cardiology; Committee for Practice Guidelines. European Society of Cardiology. American college of cardiology/european society of cardiology clinical expert consensus document on hypertrophic cardiomyopathy. A report of the american college of cardiology foundation task force on clinical expert consensus documents and the european society of cardiology committee for practice guidelines 95
A Recessive Variant of the Romano-Ward Long QT Syndrome 95
SUDDEN CARDIAC DEATH 95
Sympathetic activation, ventricular repolarization and Ikr blockade: implications for the antifibrillatory efficacy of potassium channel blocking agents 95
Unexplained cardiac arrest. The need for a prospective registry. 95
2015 European Society of Cardiology Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death summarized by co-chairs 95
Gene-specific therapy with mexiletine reduces arrhythmic events in patients with long QT syndrome type 3 95
Adrenergic Arrhythmogenesis and The Long QT syndrome 94
Increased Ca2+ Sensitivity of the Ryanodine Receptor Mutant RyR2R4496C Underlies Catecholaminergic Polymorphic Ventricular Tachycardia. 94
Abnormal Propagation of Calcium Waves and Ultrastructural Remodeling in Recessive Catecholaminergic Polymorphic Ventricular Tachycardia. 94
2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: The Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of the European Society of Cardiology (ESC)Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC) 94
ACC/AHA/ESC guidelines for the management of patients with supraventricular arrhythmias-executive summary. a report of the American college of cardiology/American heart association task force on practice guidelines and the European society of cardiology committee for practice guidelines (writing committee to develop guidelines for the management of patients with supraventricular arrhythmias) Developed in Collaboration with NASPE-Heart Rhythm Society 93
Clinical profile and genetic basis of Brugada syndrome in the Chinese population. 93
Cardiac Sodium Channel Diseases 93
2015 ESC Guidelines for the Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death 93
Association of Hydroxychloroquine with QTc Interval in Patients with COVID-19 93
Loss of function associated with novel mutations of the SCN5A gene in patients with Brugada syndrome 92
Calmodulin kinase II inhibition prevents arrhythmias in RyR2(R4496C+/-) mice with catecholaminergic polymorphic ventricular tachycardia. 92
A common polymorphism associated with antibiotic-induced cardiac arrhythmia 92
Clinical presentation and outcome of Brugada syndrome diagnosed with the new 2013 criteria 92
Clinical timelines development from textual medical reports in Italian 92
ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: A report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death) Developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society 91
[Role of standard resting ECG in the assessment of sudden cardiac death risk] 91
A molecular basis for the therapy of the long QT syndrome 91
Efficacy and Limitations of Quinidine in Patients with Brugada Syndrome 91
Genetic modulators of the phenotype in the long QT syndrome: state of the art and clinical impact 90
Age and sex-related differences in the clinical manifestations of congenital long QT syndrome: findings from the International Prospective LQTS Registry 90
Universal definition of myocardial infarction. 90
La sindrome di Brugada: epidemiologia, stratificazione del rischio e management clinico. 90
2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: The Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of the European Society of Cardiology (ESC)Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC). 90
Genotype-Phenotype correlation in the Long QT Syndrome. Gene-specific triggers for life-threatening arrhythmias 89
Genetics of ion-channel disorders 89
CaMKII inhibition rectifies arrhythmic phenotype in a patient-specific model of catecholaminergic polymorphic ventricular tachycardia. 89
Survivors of out-of-hospital cardiac arrest with apparently normal heart: need for definition and standardized clinical evaluation . Consensus statement of the Joint Steering Committees of Unexpleined Cardiac Arrest Registry of Europe and of Idiophatic Ventricular Fibrillation Registry of the United States 89
Genetics of sudden death: focus on inherited channelopathies 88
Brugada and Long QT Syndrome are two different diseases: True or False? 88
Role of the JP45-calsequestrin complex on calcium entry in slow twitch skeletal muscles 88
Cost-effectiveness of Neonatal ECG as a Screening for Long QT-syndrome: A Decision Analysis Approach. 87
R Engine Cell: integrating R into the i2b2 software infrastructure. 87
CARDIO-i2b2: integrating arrhythmogenic disease data in i2b2. 87
Molecular Bases of Juvenile Sudden Cardiac Death. 87
CardioVAI: An automatic implementation of ACMG-AMP variant interpretation guidelines in the diagnosis of cardiovascular diseases 87
Evaluation of BLS-D training in lay people. 86
Risk of aborted cardiac arrest or sudden cardiac death during adolescence in the long-QT syndrome. 86
Guidelines On Diabetes, Pre-Diabetes, And Cardiovascular Diseases: Executive Summary.The Task Force on Diabetes and Cardiovascular Diseases of the European Society of Cardiology (ESC) and of the European Association for the Study of Diabetes (EASD). 86
Totale 10.422
Salva come PNG Salva come JPEG
Categoria #
all - tutte 193.166
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 193.166
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20212.113 0 0 0 0 0 415 18 489 183 475 420 113
2021/20222.393 18 6 64 22 53 124 61 138 183 113 372 1.239
2022/20237.411 879 426 86 632 730 835 7 379 3.047 34 229 127
2023/20242.867 308 512 113 276 291 700 128 156 17 84 90 192
2024/20257.508 166 703 206 263 184 284 470 712 1.690 341 644 1.845
2025/20268.458 1.315 1.208 2.229 1.538 1.976 192 0 0 0 0 0 0
Totale 42.267